Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is almost uniformly fatal; however, some improvement in overall survival has been achieved with the introduction of nanocarriers that deliver irinotecan or paclitaxel. Although it is generally assumed that nanocarriers rely principally on abnormal leaky vascul...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Invest
Asıl Yazarlar: Liu, Xiangsheng, Lin, Paulina, Perrett, Ian, Lin, Joshua, Liao, Yu-Pei, Chang, Chong Hyun, Jiang, Jinhong, Wu, Nanping, Donahue, Timothy, Wainberg, Zev, Nel, Andre E., Meng, Huan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Clinical Investigation 2017
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5409788/
https://ncbi.nlm.nih.gov/pubmed/28414297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI92284
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller